New PCR for rapid identification of Mycoplasma pneumoniae in clinical specimens from children with respiratory tract infections

Miyuki Morozumi, Satoshi Iwata, Hiroko Endo, Tomohiro Oishi, Shigeru Ohnari, Naohisa Kawamura, Haruo Kuroki, Masaaki Kobayashi, Kouta Saito, Ritsuko Sakai, Keisuke Sunakawa, Takeshi Tajima, Masahiko Nitta, Masato Nonoyama, Reiko Kobayashi, Naoko Chiba, Kimiko Ubukata

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We designed a set of primers on the 16 S rRNA gene to directly detect Mycoplasma pneumoniae by PCR in clinical specimens from patients with respiratory infections. The sensitivity of the primers was 2 CFU/tube under the following conditions: 35 cycles of 15 sec at 94°C, 15 sec at 53°C and 15 sec at 72°C/cycle. We therefore judged the PCR results to be positive if the CFU for M. pneumoniae in a clinical specimen was 1.1 × 103. The results of the PCR were obtained in about 2.5 h. We then used the PCR to examine 783 clinical specimens (epipharynx [n = 612], throat [n = 141], ear discharge [n = 12] etc.) collected from pediatric patients between May 2002 and January 2003. The PCR results were positive in 79 cases (10.1%; 58/291 cases (19.9%) corresponded to specimens from patients with pneumonia, 13/207 cases (6.3%) to specimens from patients with acute bronchitis, 2/130 cases (1.5%) to those from patients with acute pharyngitis and 2/45 cases (4.4%) to those from patients with acute upper respiratory infections. The percentage of PCR-positive cases was significantly higher among the patients with lower part respiratory tract infections (χ2 = 53.3008, p = 0.0000). Among the patients with pneumonia, 65 were diagnosed with M. pneumoniae based on a significant rise or high antibody titer for M. pneumoniae as determined by the PA or CF test, and 46 of these cases were PCR-positive (70.8%). We also investigated the correlation between the antibiotics used before PCR and the PCR results in these 65 cases. Of the total of 43 cases, 21 not treated with antibiotics before PCR and 22 cases given oral β-lactam agents ineffective against M. pneumoniae, 38 (88.4%) were PCR-positive, whereas only 3 (23.1%) of the specimens from 13 patients treated with macrolides or new quinolones effective against M. pneumoniae were PCR-positive. We concluded from these results, that the PCR is very useful in selecting suitable chemotherapeutic agents for patients not treated with antibiotics, however it may be necessary to consider the influence of days after to develop infection on PCR results.

Original languageEnglish
Pages (from-to)289-299
Number of pages11
JournalJapanese Journal of Chemotherapy
Volume51
Issue number5
Publication statusPublished - 2003 May 1
Externally publishedYes

Fingerprint

Mycoplasma pneumoniae
Respiratory Tract Infections
Polymerase Chain Reaction
Anti-Bacterial Agents
Pneumonia
Lactams
Nasopharynx
Pharyngitis
Bronchitis
Quinolones
Macrolides
Proxy
Pharynx
rRNA Genes
Ear

Keywords

  • Mycoplasma pneumoniae
  • PCR

ASJC Scopus subject areas

  • Pharmacology

Cite this

Morozumi, M., Iwata, S., Endo, H., Oishi, T., Ohnari, S., Kawamura, N., ... Ubukata, K. (2003). New PCR for rapid identification of Mycoplasma pneumoniae in clinical specimens from children with respiratory tract infections. Japanese Journal of Chemotherapy, 51(5), 289-299.

New PCR for rapid identification of Mycoplasma pneumoniae in clinical specimens from children with respiratory tract infections. / Morozumi, Miyuki; Iwata, Satoshi; Endo, Hiroko; Oishi, Tomohiro; Ohnari, Shigeru; Kawamura, Naohisa; Kuroki, Haruo; Kobayashi, Masaaki; Saito, Kouta; Sakai, Ritsuko; Sunakawa, Keisuke; Tajima, Takeshi; Nitta, Masahiko; Nonoyama, Masato; Kobayashi, Reiko; Chiba, Naoko; Ubukata, Kimiko.

In: Japanese Journal of Chemotherapy, Vol. 51, No. 5, 01.05.2003, p. 289-299.

Research output: Contribution to journalArticle

Morozumi, M, Iwata, S, Endo, H, Oishi, T, Ohnari, S, Kawamura, N, Kuroki, H, Kobayashi, M, Saito, K, Sakai, R, Sunakawa, K, Tajima, T, Nitta, M, Nonoyama, M, Kobayashi, R, Chiba, N & Ubukata, K 2003, 'New PCR for rapid identification of Mycoplasma pneumoniae in clinical specimens from children with respiratory tract infections', Japanese Journal of Chemotherapy, vol. 51, no. 5, pp. 289-299.
Morozumi, Miyuki ; Iwata, Satoshi ; Endo, Hiroko ; Oishi, Tomohiro ; Ohnari, Shigeru ; Kawamura, Naohisa ; Kuroki, Haruo ; Kobayashi, Masaaki ; Saito, Kouta ; Sakai, Ritsuko ; Sunakawa, Keisuke ; Tajima, Takeshi ; Nitta, Masahiko ; Nonoyama, Masato ; Kobayashi, Reiko ; Chiba, Naoko ; Ubukata, Kimiko. / New PCR for rapid identification of Mycoplasma pneumoniae in clinical specimens from children with respiratory tract infections. In: Japanese Journal of Chemotherapy. 2003 ; Vol. 51, No. 5. pp. 289-299.
@article{7ed64da6849e4495bd1023c85793d11c,
title = "New PCR for rapid identification of Mycoplasma pneumoniae in clinical specimens from children with respiratory tract infections",
abstract = "We designed a set of primers on the 16 S rRNA gene to directly detect Mycoplasma pneumoniae by PCR in clinical specimens from patients with respiratory infections. The sensitivity of the primers was 2 CFU/tube under the following conditions: 35 cycles of 15 sec at 94°C, 15 sec at 53°C and 15 sec at 72°C/cycle. We therefore judged the PCR results to be positive if the CFU for M. pneumoniae in a clinical specimen was 1.1 × 103. The results of the PCR were obtained in about 2.5 h. We then used the PCR to examine 783 clinical specimens (epipharynx [n = 612], throat [n = 141], ear discharge [n = 12] etc.) collected from pediatric patients between May 2002 and January 2003. The PCR results were positive in 79 cases (10.1{\%}; 58/291 cases (19.9{\%}) corresponded to specimens from patients with pneumonia, 13/207 cases (6.3{\%}) to specimens from patients with acute bronchitis, 2/130 cases (1.5{\%}) to those from patients with acute pharyngitis and 2/45 cases (4.4{\%}) to those from patients with acute upper respiratory infections. The percentage of PCR-positive cases was significantly higher among the patients with lower part respiratory tract infections (χ2 = 53.3008, p = 0.0000). Among the patients with pneumonia, 65 were diagnosed with M. pneumoniae based on a significant rise or high antibody titer for M. pneumoniae as determined by the PA or CF test, and 46 of these cases were PCR-positive (70.8{\%}). We also investigated the correlation between the antibiotics used before PCR and the PCR results in these 65 cases. Of the total of 43 cases, 21 not treated with antibiotics before PCR and 22 cases given oral β-lactam agents ineffective against M. pneumoniae, 38 (88.4{\%}) were PCR-positive, whereas only 3 (23.1{\%}) of the specimens from 13 patients treated with macrolides or new quinolones effective against M. pneumoniae were PCR-positive. We concluded from these results, that the PCR is very useful in selecting suitable chemotherapeutic agents for patients not treated with antibiotics, however it may be necessary to consider the influence of days after to develop infection on PCR results.",
keywords = "Mycoplasma pneumoniae, PCR",
author = "Miyuki Morozumi and Satoshi Iwata and Hiroko Endo and Tomohiro Oishi and Shigeru Ohnari and Naohisa Kawamura and Haruo Kuroki and Masaaki Kobayashi and Kouta Saito and Ritsuko Sakai and Keisuke Sunakawa and Takeshi Tajima and Masahiko Nitta and Masato Nonoyama and Reiko Kobayashi and Naoko Chiba and Kimiko Ubukata",
year = "2003",
month = "5",
day = "1",
language = "English",
volume = "51",
pages = "289--299",
journal = "Japanese Journal of Chemotherapy",
issn = "1340-7007",
publisher = "Japan Society of Chemotherapy",
number = "5",

}

TY - JOUR

T1 - New PCR for rapid identification of Mycoplasma pneumoniae in clinical specimens from children with respiratory tract infections

AU - Morozumi, Miyuki

AU - Iwata, Satoshi

AU - Endo, Hiroko

AU - Oishi, Tomohiro

AU - Ohnari, Shigeru

AU - Kawamura, Naohisa

AU - Kuroki, Haruo

AU - Kobayashi, Masaaki

AU - Saito, Kouta

AU - Sakai, Ritsuko

AU - Sunakawa, Keisuke

AU - Tajima, Takeshi

AU - Nitta, Masahiko

AU - Nonoyama, Masato

AU - Kobayashi, Reiko

AU - Chiba, Naoko

AU - Ubukata, Kimiko

PY - 2003/5/1

Y1 - 2003/5/1

N2 - We designed a set of primers on the 16 S rRNA gene to directly detect Mycoplasma pneumoniae by PCR in clinical specimens from patients with respiratory infections. The sensitivity of the primers was 2 CFU/tube under the following conditions: 35 cycles of 15 sec at 94°C, 15 sec at 53°C and 15 sec at 72°C/cycle. We therefore judged the PCR results to be positive if the CFU for M. pneumoniae in a clinical specimen was 1.1 × 103. The results of the PCR were obtained in about 2.5 h. We then used the PCR to examine 783 clinical specimens (epipharynx [n = 612], throat [n = 141], ear discharge [n = 12] etc.) collected from pediatric patients between May 2002 and January 2003. The PCR results were positive in 79 cases (10.1%; 58/291 cases (19.9%) corresponded to specimens from patients with pneumonia, 13/207 cases (6.3%) to specimens from patients with acute bronchitis, 2/130 cases (1.5%) to those from patients with acute pharyngitis and 2/45 cases (4.4%) to those from patients with acute upper respiratory infections. The percentage of PCR-positive cases was significantly higher among the patients with lower part respiratory tract infections (χ2 = 53.3008, p = 0.0000). Among the patients with pneumonia, 65 were diagnosed with M. pneumoniae based on a significant rise or high antibody titer for M. pneumoniae as determined by the PA or CF test, and 46 of these cases were PCR-positive (70.8%). We also investigated the correlation between the antibiotics used before PCR and the PCR results in these 65 cases. Of the total of 43 cases, 21 not treated with antibiotics before PCR and 22 cases given oral β-lactam agents ineffective against M. pneumoniae, 38 (88.4%) were PCR-positive, whereas only 3 (23.1%) of the specimens from 13 patients treated with macrolides or new quinolones effective against M. pneumoniae were PCR-positive. We concluded from these results, that the PCR is very useful in selecting suitable chemotherapeutic agents for patients not treated with antibiotics, however it may be necessary to consider the influence of days after to develop infection on PCR results.

AB - We designed a set of primers on the 16 S rRNA gene to directly detect Mycoplasma pneumoniae by PCR in clinical specimens from patients with respiratory infections. The sensitivity of the primers was 2 CFU/tube under the following conditions: 35 cycles of 15 sec at 94°C, 15 sec at 53°C and 15 sec at 72°C/cycle. We therefore judged the PCR results to be positive if the CFU for M. pneumoniae in a clinical specimen was 1.1 × 103. The results of the PCR were obtained in about 2.5 h. We then used the PCR to examine 783 clinical specimens (epipharynx [n = 612], throat [n = 141], ear discharge [n = 12] etc.) collected from pediatric patients between May 2002 and January 2003. The PCR results were positive in 79 cases (10.1%; 58/291 cases (19.9%) corresponded to specimens from patients with pneumonia, 13/207 cases (6.3%) to specimens from patients with acute bronchitis, 2/130 cases (1.5%) to those from patients with acute pharyngitis and 2/45 cases (4.4%) to those from patients with acute upper respiratory infections. The percentage of PCR-positive cases was significantly higher among the patients with lower part respiratory tract infections (χ2 = 53.3008, p = 0.0000). Among the patients with pneumonia, 65 were diagnosed with M. pneumoniae based on a significant rise or high antibody titer for M. pneumoniae as determined by the PA or CF test, and 46 of these cases were PCR-positive (70.8%). We also investigated the correlation between the antibiotics used before PCR and the PCR results in these 65 cases. Of the total of 43 cases, 21 not treated with antibiotics before PCR and 22 cases given oral β-lactam agents ineffective against M. pneumoniae, 38 (88.4%) were PCR-positive, whereas only 3 (23.1%) of the specimens from 13 patients treated with macrolides or new quinolones effective against M. pneumoniae were PCR-positive. We concluded from these results, that the PCR is very useful in selecting suitable chemotherapeutic agents for patients not treated with antibiotics, however it may be necessary to consider the influence of days after to develop infection on PCR results.

KW - Mycoplasma pneumoniae

KW - PCR

UR - http://www.scopus.com/inward/record.url?scp=0037743896&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037743896&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0037743896

VL - 51

SP - 289

EP - 299

JO - Japanese Journal of Chemotherapy

JF - Japanese Journal of Chemotherapy

SN - 1340-7007

IS - 5

ER -